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Abstract
The use of mechanical ventilation in the past few decades has greatly contributed to the 
survival of critically ill neonates, both preterm and term. With this, however, has come 
an accompanied rise in certain complications and neonatal co-morbidities. Avoiding 
mechanical ventilation, or at least minimizing the time a neonate is intubated, is consid-
ered a critical goal in the care of these patients. Different modes of non-invasive ventila-
tion have developed over the course of the time to help address these issues.
Keywords: non-invasive ventilation, neonate, preterm, prematurity, continuous positive 
airway pressure (CPAP), bilevel positive airway pressure (BiPAP), nasal intermittent 
positive pressure ventilation (NIPPV), high flow nasal cannula (HFNC)
1. Introduction
Survival of premature infants has improved steadily since neonatal care became a national 
focus in the 1960’s. A key component in this improvement is improved respiratory care, espe-
cially mechanical ventilation. Increased survival of vulnerable infants, however, is associated 
with complications and co-morbidities, some of which are directly caused by invasive ven-
tilation. Therefore, minimizing exposure to mechanical ventilation is critical to the care of 
these babies. Gregory et al., in 1971, first described the use of continuous positive airway 
pressure (CPAP) to treat neonates afflicted with respiratory distress syndrome (RDS), which 
transformed respiratory care of neonates [1]. Subsequently, the use of CPAP and other forms 
of non-invasive ventilation have become the standard of care and have saved countless lives.
Non-invasive ventilation refers to any mode of respiratory support provided via the nasal 
airway of infants to support spontaneous breathing, without placement of an endotracheal 
tube. The most common non-invasive modes include nasal continuous positive airway 
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 pressure (NCPAP), non-invasive intermittent mandatory ventilation (NIMV), and humidified 
high-flow nasal cannula (HHFNC). The ultimate goal of each of these devices is to prevent 
barotrauma, volutrauma, and atelectotrauma, all of which contribute to lung injury and long-
term complications. Proposed mechanisms of lung protection due to non-invasive ventilation 
include mitigation of shear-type injury by maintenance of optimal end-expiratory lung vol-
umes and prevention of cyclical collapse and over-distention of alveoli. Other potential ben-
efits include lung-recruitment, improved gas exchange, and decreased work of breathing [2].
In this chapter, we will first explore historical aspects of the development of non-invasive ven-
tilation in neonates. Then we will focus on specific respiratory mechanics unique to neonates 
and post-uterine adaptation. Finally, we will discuss specific non-invasive modalities.
2. Historical perspectives
Improved perinatal care, the advent of parenteral nutrition, advances in thermoregulation, 
and aggressive neonatal resuscitation have all contributed enormously to improved outcomes 
for neonates. Perhaps the most significant change, however, is a marked improvement in our 
ability to provide aggressive and sophisticated respiratory care and support to ever-smaller 
infants. In this section, we will focus on the historical development of innovative approaches 
to non-invasive ventilation in tiny premature infants.
Although Gregory et al. published the first modern description of the use of CPAP to treat 
RDS, a similar device was first described in 1914 by Professor August Ritter von Reuss [2]. 
This device resembled bubble CPAP, and consisted of an oxygen tank with tubing attached 
to the equivalent of a mask-and-bag device, with a simple valve to regulate oxygen flow. 
Unfortunately, it took almost six decades for this concept to gain acceptance. Prior to Gregory’s 
description of CPAP, there was very little respiratory support that could be provided to neo-
nates. In the 1940s and 1950s, the provision of supplemental oxygen was the sole therapeutic 
option for ill neonates [3]. It was during this time that two seminal discoveries were made. 
The first was the discovery that supplemental oxygen provided benefit to ill neonates, but that 
exposure to high concentrations led to blindness due to retinopathy of prematurity (ROP) [3]. 
The second was a report by Avery and Mead in 1959 describing increased surface tension in 
lung fluid recovered from preterm babies that had died from respiratory distress syndrome, 
and the observation that preterm infants lacked some sort of “surface-active agent” that could 
alleviate these forces [4].
Neonatology was still a relatively new field in the latter part of the 20th century, and 1963 was 
a pivotal year in its development. President John F. Kennedy’s son, Patrick Bouvier Kennedy, 
was born 6 weeks prematurely and died from complications of respiratory distress syndrome 
on the third day of life [3]. This inspired rapid innovation in the development of new technol-
ogies geared towards critically ill neonates. Infant ventilators, blood gas machines, umbilical 
vascular catheterization and the development of the first true neonatal intensive care units all 
occurred in the late 1960s. As the field improved, survival rates for neonates with respiratory 
compromise began to improve as well, mainly due to the widespread use of infant ventilators. 
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Unfortunately, these advances were also associated with complications and many of these 
neonates were left with a form of chronic lung disease. This was first described in 1967 by 
Northway et al., who noted that prolonged exposure to mechanical ventilation and supple-
mental oxygen were likely to blame [5].
Subsequently, in 1971, Gregory et al., described the use of CPAP to treat neonates with respi-
ratory distress syndrome, using either an endotracheal tube or a head box [2]. This use of 
CPAP represented an intermediate step that was more supportive than supplemental oxygen 
alone, was relatively easy to use, and seemed to avoid exposure to the injury associated with 
mechanical ventilation. The introduction of CPAP in neonates was not the only milestone 
that this decade produced; in 1972, Liggins and Howie published the results of a randomized 
controlled trial of antenatal steroids in mothers expected to delivery premature infants. They 
demonstrated that steroids accelerated fetal lung maturation and decreased the risk of respi-
ratory distress syndrome and death by as much as half [3].
Despite the successes associated with CPAP and antenatal steroids, there were substantial con-
cerns about risks. Specifically, some observers suggested that air leaks and pneumothoraces 
were more common with CPAP than mechanical ventilation. In addition, CPAP seemed to lead 
to gastric and abdominal distention of unclear clinical significance. Finally, there were fears that 
the devices themselves would predispose infants to neurological and cosmetic injury [2]. For 
these among other reasons, intermittent mandatory ventilation using an endotracheal tube was 
widely adopted, and quickly overtook CPAP as the standard of respiratory care for critically 
ill neonates. In addition, for about two decades, CPAP was largely replaced by non-invasive 
intermittent mandatory ventilation (NIMV). It involved using time-cycled, pressure-controlled 
breaths delivered by a mechanical ventilator via an oronasal mask or prongs [2].
In the late 1980s, there was renewed interest in CPAP and non-invasive ventilation, sparked 
by the seminal report in 1987 by Avery et al. which concluded that, among eight NICUs 
observed, the center with the most aggressive use of NCPAP had the lowest rates of chronic 
lung disease [6]. Coupled with the fact that the landscape of chronic lung disease, as origi-
nally described in 1967, was changing in both a clinical and histological sense due to pro-
longed exposure to mechanical ventilation, it was no surprise that non-invasive ventilation 
was resurgent. While CPAP was originally designed for the premature baby with respiratory 
distress syndrome, today it has multiple uses in neonates of varying ages and conditions. 
It is used to successfully treat transient tachypnea of the newborn, congenital pneumonia, 
meconium aspiration syndrome, primary pulmonary hypertension, as well as central apnea 
of prematurity and certain congenital upper airway lesions [2]. While the technology has cer-
tainly evolved quite a bit since Professor von Reuss’ initial apparatus in 1914, CPAP and other 
forms of non-invasive ventilation have become the cornerstones of neonatal respiratory care.
3. Neonatal pulmonary mechanics
It is important to understand the core concepts of fetal and neonatal lung development, as 
well as basic pulmonary mechanics, to better understand the most appropriate respiratory 
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support modality. Fundamentally, the respiratory system is designed for the conduction 
and humidification of air into the lungs, uptake of oxygen from the ambient environ-
ment, and the removal of waste product in the form of carbon dioxide. All of this ensures 
that normal aerobic cellular metabolism is supported and that acid–base homeostasis is 
maintained.
The respiratory system develops through five distinct, yet overlapping phases: embryonic, 
pseudoglandular, canalicular, saccular, and alveolar [7]. While a full review of the embryology 
is not necessary for the understanding of neonatal respiratory care, it is important to note 
that each particular phase leads to unique respiratory difficulties and opportunities. Lung 
growth begins in the third week of gestation during the embryonic phase, with a small growth 
of diverticulum from the ventral wall of the foregut. This is often referred to as the primitive 
respiratory diverticulum or primitive lung bud [7]. Three rounds of branching and division 
also occur during this phase, leading to a left & right half as well as the formation of multiple 
tertiary bronchi. The vascular components of the respiratory system also begin their devel-
opment during this phase. The pseudoglandular phase occurs from weeks 5–17, and this time 
period is notable for the completion of all bronchial divisions as well as formation of cilia and 
cartilage [8]. After this phase, any further lung growth is simply by the elongation, widen-
ing and hypertrophy of existing tissue. The canalicular phase is particularly important, as it 
encompasses 16–26 weeks of development and includes neonates of periviable gestational 
ages (ie, around 23 weeks gestation). Here, the earliest capillary beds begin to form, and areas 
of gas exchange start to develop. Many of the overlying epithelial cells also begin to thin out 
and improve the air-blood interface, further enhancing regions of gas exchange. More impor-
tantly, these cells also start to differentiate into type I pneumocytes that help form and stabi-
lize the alveoli. Type II pneumocytes also start to appear, and these cells are vitally important 
in the production of endogenous surfactant [7, 8]. The canalicular stage is the earliest ges-
tational age at which interventions can be provided. The saccular phase occurs from weeks 
24–38 and leads to further development of alveolar ducts and conducting airways. Mucous 
and cilated cell growth also increases. Surfactant synthesis continues to improve, but overall 
production compared to full-term infants remains low [9]. This time period encompasses the 
bulk of premature infants, including those that are “late preterm.” The relative structural 
immaturity coupled with insufficient (and often ineffective) surfactant production explains 
the need for respiratory support in this age group, even in infants born beyond 34 weeks ges-
tation. Finally, the alveolar phase occurs from about 36 weeks – 8 years of age. This final stage 
is mainly characterized by further development of alveolar units, thinning of the air-blood 
interface, increased surface area for gas exchange, and increased numbers of type II pneumo-
cytes, leading to enhanced synthesis of surfactant [7].
Throughout fetal development, fetal lung fluid is vital in the growth of normal lung structure. 
Fetal lung fluid is an isotonic fluid secreted by epithelial cells that helps promote growth and 
development. It is low in protein and high in chloride ions. Combined with contractions of 
fetal airway smooth muscle and fetal breathing in utero, these processes help promote the 
normal developmental process of lung growth. Fluid clearance is a process initiated by vari-
ous labor mechanisms, and this also presents an area for maladaptation and one etiology of 
respiratory distress after birth [10].
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Lung function in neonates, especially those born prematurely, is altered for a number of rea-
sons. Structural issues include poorly developed lung parenchyma, airways and a highly 
elastic chest wall, and surfactant deficiency complicates these issues. This results in dramatic 
changes in normal lung mechanics and physiology, manifested by an overall state of abnor-
mally decreased compliance, low functional residual capacity (FRC), and increased respi-
ratory effort by the neonate [8]. This is further compounded by deranged gas exchange. If 
undertreated, each of these mechanisms may combine to cause respiratory failure. Antenatal 
steroids improve some of the structural and biochemical derangements, but post-natally the 
clinician must provide the correct level of respiratory support and surfactant when appropri-
ate. The goal, as we will discuss, is resolve the skewed lung mechanics towards a more normal 
physiologic state by re-establishing FRC and decreasing work of breathing.
Functional residual capacity (FRC) is defined as the volume of air remaining in the lungs after 
a normal passive exhalation [8]. In most term, healthy neonates, this figure is typically about 
20–30 mL/kg. To understand the significance of FRC in the management of neonatal respi-
ratory care, it is important to understand normal transitional events in early postnatal life. 
During gestation, the developing fetus is entirely dependent on the placenta for gas exchange. 
This in-utero circulatory pattern consists of very limited pulmonary blood flow with intra-
cardiac shunts in place to allow for adequate flow of blood to vital organs. The approximate 
oxygen saturation in a term fetus prior to delivery is about 60% [2]. When labor is initiated, 
epithelial lung cells halt their production of fetal lung fluid and begin to actively absorb it 
back into circulation. This process is triggered by thyroid hormone, glucocorticoids and epi-
nephrine working in combination to change epithelial cells from chloride secreting to sodium 
reabsorption [11]. With the neonate’s first spontaneous breaths, the lungs inflate and there is 
an increase in pulmonary arterial pO2 as well as activation of stretch receptors. This process, 
in conjunction with production of endogenous nitric oxide, dramatically reduces pulmonary 
vascular resistance [2]. As pulmonary vascular resistance continues to decrease, more pulmo-
nary blood flow is established and oxygen saturations steadily increase to normal postnatal 
levels. The intra-cardiac shunts at the level of the ductus arteriosus and foramen ovale close 
due to increasing arterial oxygen content and increasing systemic vascular resistance from 
clamping of the umbilical cord, respectively. This process results in physiologic changes that 
can be witnessed in real time, as most healthy term neonates will obtain oxygen saturations 
greater than 90% by about 10 minutes of life.
For gas exchange to properly occur after birth, there must be an immediate interface 
between environmental oxygen and pulmonary blood flow at the alveolar-capillary level. 
Ventilation (V) and perfusion (Q) ratios reflect this physiologic state, and there are a num-
ber of ways that this process can be deranged. To allow for a normal VQ matching, there 
must be both an adequate alveolar gas volume and normal FRC [7]. If adequately sustained, 
either due to spontaneous respirations or assisted ventilation, FRC serves as an intrapul-
monary pool of oxygen. Preterm infants and ill term infants are prone to a low FRC. This 
may lead to decreased  compliance, increased airway resistance, increased work of breath-
ing, increased pulmonary vascular resistance, hypoxemia, atelectasis, and impaired gas 
exchange [8]. Conversely, too much FRC from overinflation can also have negative effects 
and may lead to lung injury, air leaks and decreased cardiac output. Positive distending 
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pressure is therefore critical in recruiting collapsed alveoli and establishing optimal FRC in 
neonates that cannot achieve it spontaneously (Figure 1).
Specific mechanical and physical properties of the lung also play an important role in neo-
natal respiratory care. The elasticity of a system refers to the property of matter such that a 
system will tend to return to its original position when all external forces are abated [8]. In 
the neonate, the elastic properties of the lung refer to not just the parenchyma, but also the air 
exchange spaces, muscle, connective tissue and vasculature. In addition, there is also a recoil 
effect from surface tension in the alveoli, which is artificially increased with impaired sur-
factant production. Lastly, there are opposing elastic forces that may be provide by the chest 
wall to assist with lung expansion and air entry. All of these elastic forces form a complex, 
interdependent balance that may determine FRC [8].
The pressure required to inflate a lung is directly proportional to the volume of inflation – this 
is often referred to as Hooke’s Law [7]. While this relationship is often seen as an extension of 
the elastic properties of the lung, it brings us to our next biophysical property of respiratory 
physiology. The compliance of a lung is strictly defined as the change in lung volume due to 
a change in distending pressure during normal breathing, expressed as a ratio [8]. This is an 
extension of Hooke’s Law. Compliance may be further divided into static and dynamic com-
pliance. Static compliance refers to the tendency of the lung to recoil to its original dimensions 
after a known volume of pressure is applied and then removed [2]. Dynamic compliance, on 
the other hand, is measured during spontaneous breathing and refers to the change in pres-
sure from the end of exhalation to the end of inspiration for a given volume. It reflects both 
the intrinsic elastic and resistive properties of the lung [2]. The compliance of a given respira-
tory system includes both the lung and the chest wall. In neonates, the chest wall is primarily 
made up of cartilage and thus is a high compliance system. Conversely, the compliance of the 
Figure 1. Compliance curve demonstrating different states of FRC. Area A represents poor lung volumes or collapse, 
where area C represents over distension of the lung. Area B demonstrates optimal lung volumes in which normal 
physiological FRC is maintained. Image used with permission by Elsevier Books, Inc.
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lung is relatively low given surfactant deficiency and decreased alveolar radius, especially 
in premature infants [7]. This is a problematic scenario, as the balance of forces thereby is 
tilted towards lung collapse. This also negatively impacts FRC. Neonates respond by aug-
menting their FRC by increasing expiratory resistance through laryngeal abduction, clini-
cally manifested as “grunting” [7]. Additionally, the higher respiratory rates seen in infants 
in  low-compliant states creates relative gas trapping that helps slightly improve FRC [2]. The 
definitive treatment, however, is to deliver optimal PEEP via CPAP or another non-invasive 
modality to avoid atelectotrauma and to re-establish and sustain FRC (Figure 2).
The resistance to gas flow in a closed respiratory system is an important determinant of respi-
ratory mechanics in neonates. Resistance is the direct result of friction, and can be defined as 
either viscous or airway resistance [2]. Viscous resistance refers to the resistance encountered 
by tissue elements as they touch and move past one another. Airway resistance refers to the 
resistance that occurs between moving gas molecules and between these molecules and the 
walls of the respiratory system [2]. Airway resistance makes up the majority of total resistance 
in a neonate. It is determined by the relationship between the velocity of gas flow, length of 
the airways, viscosity of the gas, and the diameter of the conducting airways. For laminar 
flow where all gas molecules move in an orderly fashion perfectly parallel to the walls of 
the airway, resistance is described by Poiseuille’s law. This states that resistance is directly 
proportional to the product of the tube length and gas viscosity, and inversely proportional 
the airway radius to the fourth power [2]. Thus airway diameter is the critical determinant 
Figure 2. Comparison of compliance curves between a normal neonate (solid line) versus that of a neonate with RDS 
(dotted line). Note the very little volume change for an applied pressure seen in the infant with RDS due to the lack of 
surfactant and poor alveolar stabilization. Image used with permission by Elsevier Books, Inc.
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of airway resistance, as even small changes in airway radius will have exponential effects on 
resistance. This effect in neonates is especially exaggerated as they have narrow airways rela-
tive to adults.
There is an inverse, nonlinear relationship between airway resistance and lung volume. This 
is due to the fact that airway size increases as FRC increases, therefore decreasing the total 
resistance of the system [2]. The converse is also true: any pathologic state in which low 
lung volumes occur will increase the airway resistance of that system. This is another lung 
mechanical property that is affected by the FRC. That is, application of adequate PEEP via 
non-invasive ventilation will establish optimal FRC, increase airway size, and decrease air-
way resistance [2].
One final concept to explore is work of breathing. Clinically, this term refers to the signs of 
respiratory distress exhibited by a patient. This can be manifested by tachypnea, grunting, 
intercostal retractions, or nasal flaring. Mathematically, work of breathing can be quantified 
as the energy needed to overcome the existing elastic and resistive forces. More specifically, 
this can be defined as the product of the force exerted and the volume of air displaced [2]. 
About two-thirds of this energy expenditure is used to overcome the elastic forces of the 
respiratory system, while one-third is used to overcome resistance [2]. While most clinicians 
recognize that a neonate exhibiting increased work of breathing is at risk for respiratory dete-
rioration, it is important to realize that increased energy expenditure also results in increased 
oxygen consumption [8]. It is apparent that work of breathing can be decreased by the appli-
cation of positive pressure via CPAP or some other non-invasive modality – but how? Of all 
the respiratory muscles, the diaphragm carries the majority of the workload. Like most skele-
tal muscles, its ability to generate optimal force is related to its initial relaxed position and the 
length of muscle fibers at the beginning of contraction [2]. Delivering PEEP via CPAP will not 
only help better inflate the lungs, but move the diaphragm into a more optimal position for 
contraction. In addition, PEEP may prevent atelectasis and move the neonate to a more ideal 
position on the pressure-volume curve where either extreme in atelectasis or over-distended 
are avoided, and instead optimal FRC is achieved [2, 12]. Lastly, one major role of the naso-
pharynx and lining of the upper airway is to provide warmth and moisture to inspired air. 
Non-invasive ventilation replaces the warming and humidification process required by the 
neonate, and in turn this may reduce metabolic demand [13].
4. Interface devices for providing non-invasive ventilation
Since Gregory’s initial description of CPAP via a head-box, the technology used to provide 
continuous distending pressure to neonates has greatly evolved, first with the introduction of 
binasal prongs. Subsequently, both Kattwinkel et al. and Caliumi-Pellegrini et al. described 
non-invasive devices in which binasal prongs were connected to a ventilator to provide both 
flow and pressure [2]. This approach remained standard for a number of years. While the lat-
ter parts of this chapter will focus on each of the specific non-invasive modalities themselves, 
there is a considerable amount of overlap in terms of using the interface devices.
Noninvasive Ventilation in Medicine - Recent Updates68
Devices such as “head boxes” or negative pressure boxes are purely of historical interest and 
are no longer in clinical practice. Facial masks can be used to provide CPAP provided that the 
mask is attached to a flow-inflating bag or a T-piece resuscitator (for more precise pressures 
generated). This is a commonly used approach in the delivery room for initial stabilization of 
neonates, but rarely used in a prolonged manner. Nasal masks, on the other hand, are often 
used to provide long-term support to neonates receiving non-invasive ventilation. This is typ-
ically with variable-flow devices or SiPAP [8]. Nasal prongs, however, are the most popular 
and effective way to provide non-invasive ventilation. Neonates are obligate nasal breathers 
so prongs provide the most reliable way of delivering consistent distending pressure [8]. If 
the infant’s mouth is open, however, a large leak of pressure may occur and the neonate will 
not receive prescribed distending pressure. This may be addressed by using a chin strap or 
pacifier to keep the mouth closed. One other area where leak and loss of pressure can occur 
is at the nares; it is vital for nasal prongs to be large enough to fill the space within the nares 
to prevent this, but at the same time not so wide that they injure the surrounding mucosa and 
tissues [2, 8]. Long, thin prongs are generally avoided as they may increase the resistance in 
the system and even minor secretions can lead to significant obstruction and increased work 
of breathing. Endotracheal tubes are sometimes cut and used as “nasopharyngeal prongs.” 
This practice is less common given all the previously described advantages of shorter binasal 
prongs. In addition, a recent Cochrane review also suggested that binasal prongs are simply 
more effective [14]. While we will explore some of the complications associated with non-
invasive ventilation later in the chapter, skin and nasal trauma is perhaps the most commonly 
encountered issue. Adequate skin care requires assiduous nursing care, and often skin barri-
ers are applied.
The pressure delivered by CPAP is typically via a continuous or variable flow device. 
Continuous flow was the method originally used in the 1970s and 1980s, and historically 
relied on gas flow generated from a ventilator [2]. Continuous-flow CPAP is still used 
today, typically via bubble or water-seal CPAP; this will be described in detail later in this 
chapter. Two of the most commonly used binasal prongs in continuous-flow CPAP are 
the Hudson (Hudson Respiratory Care, Inc., Arlington Heights, Illinois, USA) and Inca 
(Ackrad Laboratories, Inc., Cranford, New Jersey, USA) prongs. Argyle prongs are also 
occasionally used, but have fallen out of favor [14]. Many of these binasal prongs are inter-
changeable with different modes of non-invasive support, including CPAP, SiPAP/BiPAP 
or even nasal intermittent positive pressure ventilation (NIPPV) via a ventilator [15]. There 
are scant comparative studies in the literature comparing one prong type to another [2] 
(Figure 3).
Nasal masks are another avenue of providing non-invasive ventilation. The mask itself is con-
nected to the pressure generator, typically a variable-flow device. Many units alternate the 
use of nasal masks with prongs to help prevent nasal and mucosal trauma. As with prongs, 
leaks can decrease the amount of pressure delivered to the patient. Therefore a proper seal 
around the nose must be maintained at all times. Very little data exists about the safety and 
efficacy of nasal masks versus prongs, and there are currently no reported studies of using 
NIPPV via nasal mask [2, 15] (Figure 4).
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While nasal cannulae (NC) are routinely used to provide supplemental oxygen, some dis-
tending pressure can be generated. The rate of gas flow, size of the cannulae, and degree of 
leak around the nares determine the amount of pressure generated [2]. Higher flow rates 
Figure 4. An example of a typical nasal mask used to deliver NCPAP with the infant flow driver device. Image used with 
permission by Elsevier Books, Inc.
Figure 3. The Hudson NCPAP equipment very commonly used in many NICUs. Image used with permission by 
Elsevier Books, Inc.
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delivered with relatively large sized nasal cannulae is termed “high flow nasal cannulae” 
(HFNC). Often heated and humidified, the physiology of respiratory support provided by 
HFNC is different than CPAP. The primary concern with a HFNC system is that depend-
ing on the flow rate and degree of leak, very high, uncontrolled positive pressure may be 
delivered. Not all HFNC devices contain “pop-off” valves to prevent this. These concepts 
will be explored later in this chapter. Finally, the RAM Nasal Cannula (Neotech, Valencia, 
California, USA) was originally designed to provide supplemental oxygen, but is a versatile 
interface device [2]. It has been used in various forms of CPAP as well as NIPPV via a ventila-
tor. While at its core it is essentially another short binasal prong, it is designed with larger 
bore tubing to help reduce resistance and dead space. It has gained widespread use in many 
NICUs for its relative ease of use [2]. Early anecdotal reports also suggested lower rates nasal 
trauma. Concerns regarding the RAM Nasal Cannula have to do with the long segment of 
narrow tubing from the circuit connector to the prongs, creating a great deal of resistance. 
This can potentially lead to a sizeable drop in pressure and also raises concern about whether 
the clinician can accurately assess if the patient is receiving the desired distending pressure. 
It is important to also note that the use of the RAM Nasal Cannula in providing non-invasive 
ventilation is currently considered off-label use, as it is only approved for providing supple-
mental oxygen at this time.
5. Nasal continuous positive airway pressure (NCPAP)
Continuous positive airway pressure (CPAP) is positive pressure applied to the airways of 
spontaneously breathing neonates. As previously discussed, the primary function of the respi-
ratory system is to move ambient air into the lungs for gas exchange. Any factor that limits this 
basic physiology will predispose the neonate to respiratory failure [8]. The inability to establish 
and maintain adequate lung volumes is perhaps the biggest risk factor for compromise. Low 
lung volumes and the resulting atelectasis may result in ventilation-perfusion mismatch and 
intrapulmonary shunting of blood. Oxygenation is typically affected the most, and while car-
bon dioxide can generally diffuse across biological membranes easily, its removal can be ham-
pered by a low lung-volume state. Other mechanisms that contribute to respiratory distress in 
neonates include: retained lung fluid and pulmonary edema, suboptimal FRC, unstable chest 
wall with high compliance, upper airway more prone to collapse, poor laryngeal tone, and sur-
factant deficiency [8].
5.1. Physiological benefits of CPAP
CPAP alleviates many of physiologic derangements by increasing mean airway pressure and 
distending the airways to establish and maintain optimal FRC. By stabilizing and opening 
terminal alveoli, surface area for gas exchange is enhanced, and ventilation-perfusion mis-
matching is reduced. CPAP also improves diaphragmatic contractility. In addition, CPAP 
decreases the range of different opening pressure gradients between different areas of the 
lung and helps homogenize the total delivered tidal ventilations [8]. By better distending 
the individual alveolar units, CPAP also reduces the pressure needed to overcome surface 
tension. Surfactant is better preserved on the alveolar surface, further preventing atelectasis 
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and the resulting atelectotrauma. In addition, CPAP has been shown to reduce upper air-
way occlusion by increasing pharyngeal cross-sectional area and decreasing upper airway 
resistance [8]. Coupled with stabilization of the chest wall and improved compliance, CPAP 
also reduces work of breathing. Apnea of prematurity is a common issue for many neonates 
born before 35 weeks gestation. It is manifested by various episodes of apnea, bradycardia 
and oxygenation desaturation, or some combination of the three. While there is very limited 
evidence of CPAP being an effective treatment for apnea of prematurity, it is often clinically 
used in such a manner [2].
5.2. Methods of CPAP delivery
The pressure delivered via CPAP is either via a continuous flow or variable flow device. One 
of the most common methods of providing continuous-flow CPAP is what is referred to as 
bubble or water-seal CPAP [2]. Blended gas is first heated and humidified, then delivered 
to the neonate, typically via binasal prongs or a nasal mask. The distal end of the expiratory 
tubing is submerged in either 0.25% acetic acid or sterile water to a specific depth; this depth 
determines the level of CPAP generated [2]. The bubbles from the exhalation limb produce 
observable chest vibrations that could potentially enhance gas exchange. Furthermore, the 
applied gas flow rate to the CPAP device affects the degree of bubbling, suggesting that there 
may be a low-amplitude, high-frequency oscillatory effect to the lungs [13]. Initial studies that 
reported these findings, however, were using bubble CPAP delivered via a nasopharyngeal 
tube and not binasal prongs [2]. More studies are needed to determine if there exists an oscil-
latory waveform that enhances ventilation while on bubble CPAP.
Variable-flow CPAP has been in use since 1995 and was originally developed by Moa et al. 
to help reduce neonatal work of breathing [2]. These devices use dual injector jets directed 
towards each nasal prong to establish a constant airway pressure. In addition, when the 
neonate makes a spontaneous expiration, there is a “fluidic flip” in which the flow of gas 
is reversed and allowed to exit via the expiratory limb of the device. This phenomenon is 
enhanced due to the Coanda effect, in which gas tends to follow a curved surface [2]. The two 
most common variable-flow devices currently available are the Infant Flow (Cardinal Health, 
Dublin, Ohio, USA) and the Arabella system (Hamilton Medical, Reno, Nevada, USA). Some 
studies have indeed demonstrated less work of breathing and better synchrony in neonates 
on variable-flow devices compared to bubble CPAP. Others have found similar rates of extu-
bation failure after randomization to either bubble CPAP or variable-flow CPAP following 
extubation from mechanical ventilation [2]. Despite these differences in the literature, there is 
no definitive evidence to suggest one mode of CPAP is superior. Many of these studies were 
done with neonates of various gestational ages and weights, which may confound the results 
further. Clearly, the clinician must be familiar with the device(s) available to them in their 
particular units and to be comfortable with their management.
5.3. Clinical management of CPAP
Determining the optimal CPAP level should be individualized to each neonate’s underlying 
pathophysiology and should be aimed to obtain optimal without over-distention. This target 
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may change based on the neonate’s disease course and postnatal age. The use of correctly sized 
binasal prongs with a chinstrap or pacifier to keep the mouth closed (if needed) is important 
to minimize any loss of pressure. Immediately after birth, most neonates of all gestational are 
started on a level of 5 or 6 cm H₂O, with escalation to 8–10 cm H₂O as needed [2, 8]. There is 
limited evidence, however, to suggest a singular approach to initiating or changing the CPAP 
level. Again, these decisions should be driven by the underlying pathophysiology and sup-
ported by clinical and laboratory measures when necessary. Many institutions have their own 
specific guidelines and goals, especially when caring for the very low birthweight or extremely 
low birthweight infant. In general, the CPAP level is deemed appropriate when the neonate’s 
oxygenation and ventilation are satisfactory, the chest radiograph is optimally inflated, work of 
breathing is minimal, and the neonate is otherwise hemodynamically stable. When the CPAP 
level is too high, one may see signs of over-distention on the chest radiograph manifested by a 
flattened diaphragm or small heart size. Gas exchange may be worsened and, in severe cases, 
over-distention can reduce cardiac output leading to tachycardia and hypotension [8].
Weaning the neonate off CPAP is another area that should be driven by the underlying physi-
ology and any continued need for respiratory support. This is typically possible when the neo-
nate is requiring little to no supplemental oxygen, work of breathing is negligible, and there 
are few episodes of apnea, bradycardia, and desaturation [8]. While some institutions wean 
the CPAP level during this time, other institutions do not. An alternative method of weaning 
CPAP consists of “sprinting” the neonate off CPAP support for a period of time, which gradu-
ally increases until off entirely. This is not well studied and this method of “sprinting” may 
actually lead to CPAP weaning failure and may prolong the length of time ultimately spent on 
CPAP [8]. Additional questions include at what postnatal age to consider removal of CPAP, 
and what level of support (if any) should the neonate be transitioned to. The duration of 
CPAP is often driven by the neonate’s gestational age even in the absence of significant lung 
disease, as very preterm infants often benefit from longer use of CPAP while their chest walls 
mature and offset the elastic recoil of the lungs [8]. While this may vary from one institution 
to another, typical goals for removing an extremely preterm neonate from CPAP are around 
32–34 weeks postmenstrual age, when appropriate goals are achieved (ie, no work of breath-
ing and/or minimal supplemental oxygen requirement, etc). When discontinuing CPAP, the 
neonate can either be taken directly to room air or transitioned to a lesser mode of support 
(typically some form of nasal cannula). Again, much of this decision-making is driven by the 
current lung disease (if any) being treated at the time, as well as any other factors that may 
predispose the neonate to continued need for respiratory support. For example, the neonate 
that is otherwise stable on a fairly low CPAP level, has no oxygen requirement, and is grow-
ing well can reasonably be taken to room air as the initial attempt at discontinuing CPAP. The 
neonate that still has a minimal oxygen requirement but otherwise meets other criteria for 
coming off CPAP can be taken to a nasal cannula.
5.4. BiPAP and SiPAP
Bilevel CPAP (BiPAP) or sigh intermittent positive airway pressure (SiPAP) has been mar-
keted as a means of delivering alternating levels of distending pressure. Both are typically 
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used with the Infant Flow driver and can alternate between a lower and higher CPAP pres-
sure throughout the respiratory cycle; some ventilators can provide this mode as well [2]. This 
method of support is not synchronized (synchrony is currently only available in Europe and 
Canada), and the neonate breathes spontaneously at both levels of support. This potentially 
creates two distinct FRCs [16]. The CPAP levels cycle at a specific rate. The higher pressure 
level is delivered during “inspiration”, with typical values of 8–10 cm H₂O, but sometimes as 
high as 15 cm H₂O if using a patient triggered BiPAP device. Most SiPAP devices, on the other 
hand, will have a “sigh” pop-off that will prevent inspiratory PEEP from exceeding 10 cm 
H₂O. During “expiration”, the neonate will breathe the lower pressure level, with typical 
values set at 4–6 cm H₂O. A higher “inspiratory time” is typically used, with some authors 
suggested as high as 1 second [8]. Lista et al. compared outcomes in preterm neonates with 
RDS that were initially supported with CPAP versus SiPAP [16]. They found that infants sup-
ported with SiPAP had a shorter duration of mechanical ventilation overall, needed less oxy-
gen, and were discharged home sooner. A caveat of these studies is that it can be difficult to 
compare the actually distending mean airway pressure delivered between CPAP and BiPAP/
SiPAP. The latter, with alternating levels of pressure, will typically generate a pressure that 
is 2–3 cm H₂O higher than CPAP [2]. It is quite possible that it is this higher overall level of 
pressure in addition to the cyclical tidal volumes delivered that result in benefit to the infant. 
A recent study in 2016 by Victor et al. aimed to compare the use of CPAP and BiPAP in 
infants born before 30 weeks’ gestation and less than two weeks old using equivalent mean 
airway pressures [17]. They did not find any difference in extubation failures between the two 
groups, nor did they find any difference in total duration of mechanical ventilation, oxygen 
requirement at 28 days & 36 weeks corrected, or length of hospitalization.
6. Humidified high flow nasal cannula (HHFNC)
HHFNC use rapidly expanded in NICUs since 2005. The two major commercially avail-
able devices are Vapotherm (Exeter, New Hampshire, USA) and Fisher & Paykel (Auckland, 
New Zealand) [2]. While most clinicians refer to this technology as “HFNC,” the delivered 
air undergoes a heating and humidification process. Traditional nasal cannula was limited 
to flow rates of 2 lpm of either 100% or blended oxygen for neaontes [13]. Higher rates of 
flow often caused significant drying of the airway mucosa, leading to irritation and mucosal 
trauma. The new HFNC systems create nearly 100%, allowing clinicians to use higher flow 
rates. This can vary from one institution to another. Some centers will use flow rates of up to 
4 lpm, while others use rates as high as 8 lpm. Many of the same physiological benefits seen 
with the use of CPAP can be extrapolated to the use of HHFNC, as the higher flow rates has 
been shown in some studies to provide comparable distending pressure [2]. These benefits 
include improved pharyngeal tone, nasopharyngeal deadspace washout, decreased work of 
breathing, and maintenance of FRC [13]. The primary concern with the use of HHFNC is that 
it can potentially deliver unpredictable, uncontrolled and widely variable levels of distending 
pressure. Some studies using esophageal probes have measured the pressure delivered by 
HHFNC; this level is a determined not only by the flow rate delivered, but also the weight of 
the neonate and the size of the cannulae [2]. Neither of the two commercially available HHFNC 
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devices are capable of measuring the level of pressure provided. They do, however, have an 
internal pressure-limiting mechanism as a safety measure to prevent excessive pressures from 
reaching the patient [8]. Ultimately, though, there currently is no reliable way to calculate how 
much distending pressure is delivered. For that reason, it is vital that the nasal prongs selected 
allow for some leak around the nares so that extremely high pressures are avoided.
6.1. Clinical use of HHFNC
HHFNC has been tried in various domains of neonatal respiratory management, including 
as a means of avoiding extubation failure in premature neonates. There have been a handful 
of recent studies to look at this, and the general consensus seems to be that HHFNC was non-
inferior to CPAP in terms of extubation failures [8]. The additional finding of less nasal and 
mucosal trauma was consistent across most of these studies. Overall, however, there is still 
insufficient evidence to suggest that HHFNC is equal or superior to CPAP in preventing extu-
bation failure. Much of this has to do with wide variations in the previously mentioned study 
designs, use of different devices, and unknown severity of respiratory distress in enrolled 
patients [8]. These data are even more limited for extremely low birthweight infants or those 
born less than 28 weeks’ gestation [13].
HHFNC has also been studied for treatment of apnea of prematurity and work of breath-
ing. Saslow et al. (2006) evaluated the effects of CPAP and Vapotherm HFNC on work of 
breathing patterns in a crossover study of preterm infants requiring either support modality 
and weighing <2.0 kg at birth. They did not find any significant differences between the two 
groups [8]. Sreenan et al. (2011) also looked at stable premature infants in a crossover study 
of CPAP and HHFNC. They did not find any differences between the two modalities with 
respect to apnea, bradycardia, or desaturation events, oxygen requirement, or work of breath-
ing [8]. This remains an area where success with HHFNC can certainly be achieved, but it is 
important to note that no definitive evidence exists to prove it is equally efficacious as CPAP.
6.2. Current best evidence regarding HHFNC use
In June 2015, an international group of experts met in Oxford, England to discuss the use of nasal 
high-flow therapy in neonatology. The goal of the meeting was to reach consensus among clini-
cians on how to best use and study HHFNC in neonates and to try to establish guidelines for 
its management [13]. At the time of their meeting, their review encompassed four current RCTs 
that involved over 1100 preterm infants [13]. The following is summary of the group’s findings.
The Oxford group recommended that in general, HHFNC can be considered for most neo-
nates in which CPAP would be used. This includes preterm infants with respiratory distress, 
increased work of breathing, or an oxygen requirement. Special consideration should be given 
to neonates with significant nasal trauma from CPAP use, as switching to HHFNC may allow 
the nares to heal [13]. The same level of monitoring and nursing care provided to a neonate 
on CPAP should be applied to a neonate on HHFNC [13].
As previously mentioned, one of the major differences at the level of the nasal prongs between 
CPAP and HHFNC is the desired amount of leak. With HHFNC, there must be a moderate 
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amount of leak around the nares to allow gas egress and to ensure that unpredictably high 
pressures do not occur. The group concluded that the prong dimensions be no greater than 
50% of the diameter of the nares, and that the gas flow via HHFNC be heated between 34 and 
37 degrees C [13]. Furthermore, the actual cannulae used should be per manufacturer recom-
mendations, and components from different systems should not be mixed.
Individual institutions may have their own particular guidelines, but the Oxford meeting 
recommends starting with flows of 4–6 lpm for most preterm infants. Lower flow rates of 
2–3 lpm may be acceptable for larger neonates closer to or at term [13]. A maximum flow 
rate of 8 lpm is recommended, and only in response to increased work of breathing or higher 
oxygen requirements. Escalation from HHFNC to a different support modality should be 
considered in cases of increased work of breathing, increased apnea, or oxygen requirements 
greater than 50% [13]. Weaning the flow rate can be considered once the neonate is stable 
for about 24 hours and on 30% or less oxygen, with one recommended approach of weaning 
the flow rate by 1 lpm every 12 hours as tolerated. Again, institutions may have their own 
weaning protocols. Discontinuing HHFNC can be considered once flow rates of 2–4 lpm are 
achieved, as 2 lpm is actually the lowest most devices will sustain, and the benefits of rates 
less than 3 lpm are actually unclear at this point [13].
6.3. Summary
A growing body of evidence seems to suggest that HHFNC is fairly safe and efficacious 
in supporting many preterm infants, however no definitive evidence exists. Flow rates of 
2–8 lpm are generally acceptable, with careful attention to prong size and adherence to all 
manufacturer recommendations. Clearly, however, more research is needed. Specifically, 
more studies are needed to evaluate the use of HHFNC in extremely low birth weight infants 
and those born less than 27 weeks’ gestation, as well as the potential use of HHFNC in deliv-
ery room resuscitation and during neonatal transport [13]. This is one specific age group in 
which the evidence still overwhelmingly supports the use of CPAP as the initial mode of support. 
More studies are also needed to compare different HHFNC devices, types of cannulas, and 
true flow rate recommendations based on weight and gestational age. Finally, the Oxford 
group strongly recommends that each institution devise and adhere to their own agreed-
upon guidelines so that a standardized approach to the use of HHFNC can be applied and 
subsequently studied.
7. Nasal intermittent positive pressure ventilation (NIPPV)
Nasal intermittent mandatory ventilation (NIMV), also known as nasal intermittent positive 
pressure ventilation (NIPPV), refers to ventilation provided via a conventional ventilator in 
a non-invasive fashion. This is usually administered via short binasal prongs, the RAM Nasal 
Cannula, or a nasal mask [2, 8]. Depending on the type of ventilator and settings used, NIPPV 
is designed to deliver positive pressure throughout the respiratory cycle with defined, inter-
mittent increases in pressure, often in synchrony with respiratory efforts [8]. This method of 
respiratory support was initially described in the early 1970s when via time-cycled inflations 
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using a ventilator with an oronasal mask [2]. In the 1980s, more than 50% of the level III 
NICUs in Canada were consistently using this method of respiratory support. Shortly after, 
it fell out of favor due to reports of facial neurological injuries and gastrointestinal perfora-
tions; subsequent studies regarding the use of NIPPV in neonates have not reported higher 
rates of these complications [2, 13]. Of note, nasal high-frequency ventilation (NHFV) is also 
described in the literature and is increasingly common in some centers in Europe. Given its 
relative new nature and lack of extensive comparative studies, it will not be discussed here.
7.1. Benefits of NIPPV
The physiological benefits of NIPPV are similar to other modes of positive pressure delivery. 
Specifically, NIPPV will expand the lung and recruit terminal alveoli, increase FRC, pre-
vent atelectasis and atelectotrauma, and improve ventilation-perfusion mismatches [8, 18]. 
In addition, the positive pressure delivered helps splint the upper airways, improves laryn-
geal tone, and stabilizes the highly compliant neonatal chest wall. Synchronized NIPPV, or 
sNIPPV, has been shown in several studies to deliver higher tidal volumes than CPAP or 
non-synchronized NIPPV [13, 18]. In addition, all forms of NIPPV deliver additional posi-
tive pressure breaths, further increasing mean airway pressure. This in turn helps to further 
improve tidal volumes and reduces thoraco-abdominal asynchrony (especially true with 
sNIPPV), which has may reduce work of breathing and improve pulmonary mechanics [8]. 
Animal studies have also shown that the intermittent distending pressure above PEEP that 
NIPPV provides can more effectively recruit the lung than CPAP alone, leading to further 
improvements in FRC [13].
NIPPV has been studied in three major domains: preventing extubation failures, treating 
apnea of prematurity, and as the primary mode of treating respiratory distress in prema-
ture neonates. As of 2015, there have been ten randomized controlled trials comparing 
NIPPV with CPAP after extubation in premature infants. Friedlich et al. were the first to 
publish a study comparing CPAP with sNIPPV, and demonstrated that sNIPPV reduced 
extubation failures significantly [19]. In 2017, a Cochrane meta-analysis of these trials dem-
onstrated a reduction in extubation failure (NNT = 4), but the studies included various 
NIPPV devices with a mix of synchrony versus asynchrony [8]. Furthermore, there was 
variability in the definition of extubation success. Despite these caveats, the conclusion from 
the review was that NIPPV may reduce extubation failure within 48 hours to one week 
after extubation more effectively than CPAP. No effect, however, was seen on chronic lung 
disease or  mortality [18].
For treatment of apnea of prematurity, there are three studies comparing CPAP with 
NIPPV. The evidence is conflicting and there is no current recommendation whether NIPPV 
is superior to CPAP [8, 13]. A total of eight studies with 850 patients have looked at NIPPV as 
the primary mode of initial ventilation in premature neonates with respiratory distress syn-
drome, with the primary outcome being failure of non-invasive support and the need for intu-
bation. The studies included different devices with mixed populations. Furthermore, some 
studies allowed the use of surfactant while others did not. As one might imagine, the results 
were mixed, with six of the trials essentially finding no difference between the two respiratory 
modalities [8]. As mentioned above, the strongest evidence in this area as demonstrated by 
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the 2017 Cochrane review appears to be the use of NIPPV to prevent extubation failure when 
used immediately after extubation [18].
7.2. Typical NIPPV settings
As with every mode of respiratory support, the settings applied to any particular neo-
nate should be based on the particular device used and the underlying pathophysiology. 
Initial settings on NIPPV are typically similar to those of a mechanical ventilator, with 
two exceptions, applied peak inspiratory pressure (PIP) and inspiratory time (Ti). Higher 
PIP is often necessary as pressure is delivered via a nasal interface and pressure is attenu-
ated prior to delivery to the lungs. Therefore, NIPPV PIP is typically started about 2–4 cm 
H₂O higher than that normally used for mechanical ventilation via an endotracheal tube 
[8]. This is then adjusted based on adequate chest rise and blood gas measurements. For 
similar reasons, slightly higher inspiratory times of 0.4–0.5 seconds are also typical, as 
breaths delivered nasally have more resistance to overcome versus those delivered via an 
endotracheal tube.
Weaning from conventional ventilator to NIPPV should be done according to the same gen-
eral recommendations as for any other mode. The goal should be well inflated lungs with 
an adequate FRC and minimal work of breathing. Settings on NIPPV are typically similar 
to prior settings on mechanical ventilation at the time of extubation. While this will differ 
from one institution to the next, this typically consists of rates below 25 breaths/min, a PIP of 
less than 20 cm H₂O, and an oxygen requirement of less than 30–35%. PEEP can be variable 
depending on oxygen requirement and need for lung expansion, but ideally will be 6 cm H₂O 
or less [8].
8. Summary
Although the means of delivering non-invasive respiratory support are widely variable, with 
numerous interfaces, devices and modes, the underlying goal is the same for all. Each baby’s 
physiology should be assessed and non-invasive respiratory support must be tailored to 
resolve the most important underlying pathophysiology. When properly supported, babies 
should be well oxygenated, with minimal work of breathing, infrequent apnea, and a stable 
respiratory status.
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